AI-generated summary
The authors randomized 40 patients with unilateral breast cancer-related lymphedema to photobiomodulation therapy or placebo over eight sessions using a cluster laser. They report a 50% reduction in median pain scores and improved quality of life after treatment, but no statistically significant intergroup differences in quality of life, pain, grip strength or limb volume over time.
- Participants
- 40
- Who or what was studied
- Patients with unilateral breast cancer-related lymphedema
- Limits stated in the abstract
- The abstract reports no statistically significant intergroup differences over the time course and does not state the wavelength used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Placebo-controlled, Laser, Beam area, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.